In today’s episode, I talk with Sarah Kennedy, founder and CEO of Calocurb, about a plant based approach to appetite management built on years of research in New Zealand. We break down how her capsule works in the upper intestine to stimulate the body’s own appetite suppressing hormones, why that differs from synthetic GLP 1 drugs, and what the clinical results show around hunger, cravings, and calorie intake. We also talk about the myth of willpower, how the hind brain drives eating behavior, and why coming off injectable solutions can trigger intense rebound hunger.
